APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Orally Disintegrating Tablet Excipient

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications.An excipient is a pharmacologically inert adhesive substance used to bind the contents of a pill or tablet. This type of tablet separates in the mouth in contact with saliva, making it easy for a person to swallow the tablet without drinking water.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications.An excipient is a pharmacologically inert adhesive substance used to bind the contents of a pill or tablet. This type of tablet separates in the mouth in contact with saliva, making it easy for a person to swallow the tablet without drinking water.

Selected research

Market Structure

Global Orally Disintegrating Tablet Excipient Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174020370319 December 2025194 pages

Choose your research edition.

Industry ResearchOrally Disintegrating Tablet Excipient Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Orally Disintegrating Tablet Excipient Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Orally Disintegrating Tablet Excipient Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Orally Disintegrating Tablet Excipient Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Orally Disintegrating Tablet Excipient Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications.An excipient is a pharmacologically inert adhesive substance used to bind the contents of a pill or tablet. This type of tablet separates in the mouth in contact with saliva, making it easy for a person to swallow the tablet without drinking water.

McePharma (Vivesa holding) was the global greatest company in Orally Disintegrating Tablet Excipient industry, with the revenue market Share of 3% , followed by BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, Fuji Chemical Industries, Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical.APAC is the largest Orally Disintegrating Tablet Excipient market with about 30% market share. Americas is follower, accounting for about 27% market share.

This report provides an overview of the global Orally Disintegrating Tablet Excipient market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Orally Disintegrating Tablet Excipient and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Orally Disintegrating Tablet Excipient sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Orally Disintegrating Tablet Excipient market size, projected growth trends, production technologies, key applications, and end-use industries.

Orally Disintegrating Tablet Excipient Segment by Company

BASF

JRS Pharma

Roquette

ABF Ingredients

DFE Pharma

Evonik

Merck KGaA

Ashland

Meggle Pharma

Shin-Etsu

Fuji Chemical Industries

McePharma (Vivesa holding)

Cargill Incorporated

Daicel Corporation

Anhui Sunhere Pharmaceutical

Orally Disintegrating Tablet Excipient Segment by Type

Binders

Glidents

Diluents

Disintegrants

Others

Orally Disintegrating Tablet Excipient Segment by Application

Anti-Psychotics Drug

Anti-Epileptics Drug

Others

Orally Disintegrating Tablet Excipient Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Orally Disintegrating Tablet Excipient market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Orally Disintegrating Tablet Excipient and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Orally Disintegrating Tablet Excipient.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Orally Disintegrating Tablet Excipient market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Orally Disintegrating Tablet Excipient manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Orally Disintegrating Tablet Excipient in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Orally Disintegrating Tablet Excipient in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Orally Disintegrating Tablet Excipient Industry Trends Table 2. Orally Disintegrating Tablet Excipient Industry Drivers Table 3. Orally Disintegrating Tablet Excipient Industry Opportunities and Challenges Table 4. Orally Disintegrating Tablet Excipient Industry Restraints Table 5. Global Orally Disintegrating Tablet Excipient Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Orally Disintegrating Tablet Excipient Sales by Manufacturers (K MT) & (2021-2026) Table 8. Global Orally Disintegrating Tablet Excipient Sales Market Share by Manufacturers Table 9. Global Orally Disintegrating Tablet Excipient Average Sales Price (USD/MT) of Manufacturers (2021-2026) Table 10. Global Orally Disintegrating Tablet Excipient Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Orally Disintegrating Tablet Excipient Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Orally Disintegrating Tablet Excipient Manufacturers, Product Type & Application Table 13. Global Orally Disintegrating Tablet Excipient Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Orally Disintegrating Tablet Excipient by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Binders Table 17. Major Manufacturers of Glidents Table 18. Major Manufacturers of Diluents Table 19. Major Manufacturers of Disintegrants Table 20. Major Manufacturers of Others Table 21. Global Orally Disintegrating Tablet Excipient Sales by Type 2021 VS 2025 VS 2032 (K MT) Table 22. Global Orally Disintegrating Tablet Excipient Sales by Type (2021-2026) & (K MT) Table 23. Global Orally Disintegrating Tablet Excipient Sales by Type (2027-2032) & (K MT) Table 24. Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2021-2026) Table 25. Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2027-2032) Table 26. Global Orally Disintegrating Tablet Excipient Revenue by Type 2021 VS 2025 VS 2032 (K MT) Table 27. Global Orally Disintegrating Tablet Excipient Revenue by Type (2021-2026) & (K MT) Table 28. Global Orally Disintegrating Tablet Excipient Revenue by Type (2027-2032) & (K MT) Table 29. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2021-2026) Table 30. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Anti-Psychotics Drug Table 32. Major Manufacturers of Anti-Epileptics Drug Table 33. Major Manufacturers of Others Table 34. Global Orally Disintegrating Tablet Excipient Sales by Application 2021 VS 2025 VS 2032 (K MT) Table 35. Global Orally Disintegrating Tablet Excipient Sales by Application (2021-2026) & (K MT) Table 36. Global Orally Disintegrating Tablet Excipient Sales by Application (2027-2032) & (K MT) Table 37. Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2021-2026) Table 38. Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2027-2032) Table 39. Global Orally Disintegrating Tablet Excipient Revenue by Application 2021 VS 2025 VS 2032 (K MT) Table 40. Global Orally Disintegrating Tablet Excipient Revenue by Application (2021-2026) & (K MT) Table 41. Global Orally Disintegrating Tablet Excipient Revenue by Application (2027-2032) & (K MT) Table 42. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2021-2026) Table 43. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2027-2032) Table 44. Global Orally Disintegrating Tablet Excipient Sales by Region: 2021 VS 2025 VS 2032 (K MT) Table 45. Global Orally Disintegrating Tablet Excipient Sales by Region (2021-2026) & (K MT) Table 46. Global Orally Disintegrating Tablet Excipient Sales Market Share by Region (2021-2026) Table 47. Global Orally Disintegrating Tablet Excipient Sales Forecasted by Region (2027-2032) & (K MT) Table 48. Global Orally Disintegrating Tablet Excipient Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Orally Disintegrating Tablet Excipient Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K MT) Table 50. North America Orally Disintegrating Tablet Excipient Sales by Country (2021-2026) & (K MT) Table 51. North America Orally Disintegrating Tablet Excipient Sales by Country (2027-2032) & (K MT) Table 52. Europe Orally Disintegrating Tablet Excipient Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K MT) Table 53. Europe Orally Disintegrating Tablet Excipient Sales by Country (2021-2026) & (K MT) Table 54. Europe Orally Disintegrating Tablet Excipient Sales by Country (2027-2032) & (K MT) Table 55. Asia Pacific Orally Disintegrating Tablet Excipient Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K MT) Table 56. Asia Pacific Orally Disintegrating Tablet Excipient Sales by Country (2021-2026) & (K MT) Table 57. Asia Pacific Orally Disintegrating Tablet Excipient Sales by Country (2027-2032) & (K MT) Table 58. South America, Middle East and Africa Orally Disintegrating Tablet Excipient Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K MT) Table 59. South America, Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (2021-2026) & (K MT) Table 60. South America, Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (2027-2032) & (K MT) Table 61. Global Orally Disintegrating Tablet Excipient Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Orally Disintegrating Tablet Excipient Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Orally Disintegrating Tablet Excipient Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2021-2026) Table 65. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2027-2032) Table 66. BASF Company Information Table 67. BASF Business Overview Table 68. BASF Orally Disintegrating Tablet Excipient Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. BASF Orally Disintegrating Tablet Excipient Product Portfolio Table 70. BASF Recent Development Table 71. JRS Pharma Company Information Table 72. JRS Pharma Business Overview Table 73. JRS Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. JRS Pharma Orally Disintegrating Tablet Excipient Product Portfolio Table 75. JRS Pharma Recent Development Table 76. Roquette Company Information Table 77. Roquette Business Overview Table 78. Roquette Orally Disintegrating Tablet Excipient Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Roquette Orally Disintegrating Tablet Excipient Product Portfolio Table 80. Roquette Recent Development Table 81. ABF Ingredients Company Information Table 82. ABF Ingredients Business Overview Table 83. ABF Ingredients Orally Disintegrating Tablet Excipient Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. ABF Ingredients Orally Disintegrating Tablet Excipient Product Portfolio Table 85. ABF Ingredients Recent Development Table 86. DFE Pharma Company Information Table 87. DFE Pharma Business Overview Table 88. DFE Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. DFE Pharma Orally Disintegrating Tablet Excipient Product Portfolio Table 90. DFE Pharma Recent Development Table 91. Evonik Company Information Table 92. Evonik Business Overview Table 93. Evonik Orally Disintegrating Tablet Excipient Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Evonik Orally Disintegrating Tablet Excipient Product Portfolio Table 95. Evonik Recent Development Table 96. Merck KGaA Company Information Table 97. Merck KGaA Business Overview Table 98. Merck KGaA Orally Disintegrating Tablet Excipient Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Merck KGaA Orally Disintegrating Tablet Excipient Product Portfolio Table 100. Merck KGaA Recent Development Table 101. Ashland Company Information Table 102. Ashland Business Overview Table 103. Ashland Orally Disintegrating Tablet Excipient Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Ashland Orally Disintegrating Tablet Excipient Product Portfolio Table 105. Ashland Recent Development Table 106. Meggle Pharma Company Information Table 107. Meggle Pharma Business Overview Table 108. Meggle Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Meggle Pharma Orally Disintegrating Tablet Excipient Product Portfolio Table 110. Meggle Pharma Recent Development Table 111. Shin-Etsu Company Information Table 112. Shin-Etsu Business Overview Table 113. Shin-Etsu Orally Disintegrating Tablet Excipient Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Shin-Etsu Orally Disintegrating Tablet Excipient Product Portfolio Table 115. Shin-Etsu Recent Development Table 116. Fuji Chemical Industries Company Information Table 117. Fuji Chemical Industries Business Overview Table 118. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product Portfolio Table 120. Fuji Chemical Industries Recent Development Table 121. McePharma (Vivesa holding) Company Information Table 122. McePharma (Vivesa holding) Business Overview Table 123. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product Portfolio Table 125. McePharma (Vivesa holding) Recent Development Table 126. Cargill Incorporated Company Information Table 127. Cargill Incorporated Business Overview Table 128. Cargill Incorporated Orally Disintegrating Tablet Excipient Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Cargill Incorporated Orally Disintegrating Tablet Excipient Product Portfolio Table 130. Cargill Incorporated Recent Development Table 131. Daicel Corporation Company Information Table 132. Daicel Corporation Business Overview Table 133. Daicel Corporation Orally Disintegrating Tablet Excipient Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Daicel Corporation Orally Disintegrating Tablet Excipient Product Portfolio Table 135. Daicel Corporation Recent Development Table 136. Anhui Sunhere Pharmaceutical Company Information Table 137. Anhui Sunhere Pharmaceutical Business Overview Table 138. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales (K MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product Portfolio Table 140. Anhui Sunhere Pharmaceutical Recent Development Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Orally Disintegrating Tablet Excipient Distributors List Table 144. Orally Disintegrating Tablet Excipient Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Orally Disintegrating Tablet Excipient Product Image Figure 2. Global Orally Disintegrating Tablet Excipient Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Orally Disintegrating Tablet Excipient Market Size (2021-2032) & (US$ Million) Figure 4. Global Orally Disintegrating Tablet Excipient Sales (2021-2032) & (K MT) Figure 5. Global Orally Disintegrating Tablet Excipient Average Price (USD/MT) & (2021-2032) Figure 6. Global Top 5 and 10 Orally Disintegrating Tablet Excipient Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Binders Image Figure 9. Glidents Image Figure 10. Diluents Image Figure 11. Disintegrants Image Figure 12. Others Image Figure 13. Global Orally Disintegrating Tablet Excipient Sales by Type (2021 VS 2025 VS 2032) & (K MT) Figure 14. Global Orally Disintegrating Tablet Excipient Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2021-2032) Figure 16. Global Orally Disintegrating Tablet Excipient Revenue by Type (2021 VS 2025 VS 2032) & (K MT) Figure 17. Global Orally Disintegrating Tablet Excipient Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2021-2032) Figure 19. Anti-Psychotics Drug Image Figure 20. Anti-Epileptics Drug Image Figure 21. Others Image Figure 22. Global Orally Disintegrating Tablet Excipient Sales by Application (2021 VS 2025 VS 2032) & (K MT) Figure 23. Global Orally Disintegrating Tablet Excipient Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2021-2032) Figure 25. Global Orally Disintegrating Tablet Excipient Revenue by Application (2021 VS 2025 VS 2032) & (K MT) Figure 26. Global Orally Disintegrating Tablet Excipient Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2021-2032) Figure 28. North America Orally Disintegrating Tablet Excipient Sales and Growth Rate (2021-2032) & (K MT) Figure 29. North America Orally Disintegrating Tablet Excipient Sales Market Share by Country (2021-2032) Figure 30. U.S. Orally Disintegrating Tablet Excipient Sales and Growth Rate (2021-2032) & (K MT) Figure 31. Canada Orally Disintegrating Tablet Excipient Sales and Growth Rate (2021-2032) & (K MT) Figure 32. Mexico Orally Disintegrating Tablet Excipient Sales and Growth Rate (2021-2032) & (K MT) Figure 33. Europe Orally Disintegrating Tablet Excipient Sales and Growth Rate (2021-2032) & (K MT) Figure 34. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Country (2021-2032) Figure 35. Germany Orally Disintegrating Tablet Excipient Sales and Growth Rate (2021-2032) & (K MT) Figure 36. France Orally Disintegrating Tablet Excipient Sales and Growth Rate (2021-2032) & (K MT) Figure 37. U.K. Orally Disintegrating Tablet Excipient Sales and Growth Rate (2021-2032) & (K MT) Figure 38. Italy Orally Disintegrating Tablet Excipient Sales and Growth Rate (2021-2032) & (K MT) Figure 39. Netherlands Orally Disintegrating Tablet Excipient Sales and Growth Rate (2021-2032) & (K MT) Figure 40. Asia Pacific Orally Disintegrating Tablet Excipient Sales and Growth Rate (2021-2032) & (K MT) Figure 41. Asia Pacific Orally Disintegrating Tablet Excipient Sales Market Share by Country (2021-2032) Figure 42. China Orally Disintegrating Tablet Excipient Sales and Growth Rate (2021-2032) & (K MT) Figure 43. Japan Orally Disintegrating Tablet Excipient Sales and Growth Rate (2021-2032) & (K MT) Figure 44. South Korea Orally Disintegrating Tablet Excipient Sales and Growth Rate (2021-2032) & (K MT) Figure 45. Southeast Asia Orally Disintegrating Tablet Excipient Sales and Growth Rate (2021-2032) & (K MT) Figure 46. India Orally Disintegrating Tablet Excipient Sales and Growth Rate (2021-2032) & (K MT) Figure 47. Australia Orally Disintegrating Tablet Excipient Sales and Growth Rate (2021-2032) & (K MT) Figure 48. South America, Middle East and Africa Orally Disintegrating Tablet Excipient Sales and Growth Rate (2021-2032) & (K MT) Figure 49. South America, Middle East and Africa Orally Disintegrating Tablet Excipient Sales Market Share by Country (2021-2032) Figure 50. Brazil Orally Disintegrating Tablet Excipient Sales and Growth Rate (2021-2032) & (K MT) Figure 51. South Africa Orally Disintegrating Tablet Excipient Sales and Growth Rate (2021-2032) & (K MT) Figure 52. Saudi Arabia Orally Disintegrating Tablet Excipient Sales and Growth Rate (2021-2032) & (K MT) Figure 53. Turkey Orally Disintegrating Tablet Excipient Sales and Growth Rate (2021-2032) & (K MT) Figure 54. Argentina Orally Disintegrating Tablet Excipient Sales and Growth Rate (2021-2032) & (K MT) Figure 55. UAE Orally Disintegrating Tablet Excipient Sales and Growth Rate (2021-2032) & (K MT) Figure 56. Egypt Orally Disintegrating Tablet Excipient Sales and Growth Rate (2021-2032) & (K MT) Figure 57. Chile Orally Disintegrating Tablet Excipient Sales and Growth Rate (2021-2032) & (K MT) Figure 58. Global Orally Disintegrating Tablet Excipient Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Figure 61. North America Orally Disintegrating Tablet Excipient Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Figure 63. Europe Orally Disintegrating Tablet Excipient Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Orally Disintegrating Tablet Excipient Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Orally Disintegrating Tablet Excipient Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Orally Disintegrating Tablet Excipient Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Orally Disintegrating Tablet Excipient Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Orally Disintegrating Tablet Excipient Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Binders
  • Glidents
  • Diluents
  • Disintegrants
  • Others
Applications
  • Anti-Psychotics Drug
  • Anti-Epileptics Drug
  • Others
Companies covered
  • BASF
  • JRS Pharma
  • Roquette
  • ABF Ingredients
  • DFE Pharma
  • Evonik
  • Merck KGaA
  • Ashland
  • Meggle Pharma
  • Shin-Etsu
  • Fuji Chemical Industries
  • McePharma (Vivesa holding)
  • Cargill Incorporated
  • Daicel Corporation
  • Anhui Sunhere Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Orally Disintegrating Tablet Excipient Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Orally Disintegrating Tablet Excipient Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Orally Disintegrating Tablet Excipient Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Orally Disintegrating Tablet Excipient Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Orally Disintegrating Tablet Excipient Market Dynamics
  1. 2.1 Orally Disintegrating Tablet Excipient Industry Trends
  2. 2.2 Orally Disintegrating Tablet Excipient Industry Drivers
  3. 2.3 Orally Disintegrating Tablet Excipient Industry Opportunities and Challenges
  4. 2.4 Orally Disintegrating Tablet Excipient Industry Restraints
3 Orally Disintegrating Tablet Excipient Market by Manufacturers
  1. 3.1 Global Orally Disintegrating Tablet Excipient Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Orally Disintegrating Tablet Excipient Sales by Manufacturers (2021-2026)
  3. 3.3 Global Orally Disintegrating Tablet Excipient Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Orally Disintegrating Tablet Excipient Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Orally Disintegrating Tablet Excipient Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Orally Disintegrating Tablet Excipient Manufacturers, Product Type & Application
  7. 3.7 Global Orally Disintegrating Tablet Excipient Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Orally Disintegrating Tablet Excipient Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Orally Disintegrating Tablet Excipient Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Orally Disintegrating Tablet Excipient Tier 1, Tier 2, and Tier 3
4 Orally Disintegrating Tablet Excipient Market by Type
  1. 4.1 Orally Disintegrating Tablet Excipient Type Introduction
  2. 4.1.1 Binders
  3. 4.1.2 Glidents
  4. 4.1.3 Diluents
  5. 4.1.4 Disintegrants
  6. 4.1.5 Others
  7. 4.2 Global Orally Disintegrating Tablet Excipient Sales by Type
  8. 4.2.1 Global Orally Disintegrating Tablet Excipient Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Orally Disintegrating Tablet Excipient Sales by Type (2021-2032)
  10. 4.2.3 Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2021-2032)
  11. 4.3 Global Orally Disintegrating Tablet Excipient Revenue by Type
  12. 4.3.1 Global Orally Disintegrating Tablet Excipient Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Orally Disintegrating Tablet Excipient Revenue by Type (2021-2032)
  14. 4.3.3 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2021-2032)
5 Orally Disintegrating Tablet Excipient Market by Application
  1. 5.1 Orally Disintegrating Tablet Excipient Application Introduction
  2. 5.1.1 Anti-Psychotics Drug
  3. 5.1.2 Anti-Epileptics Drug
  4. 5.1.3 Others
  5. 5.2 Global Orally Disintegrating Tablet Excipient Sales by Application
  6. 5.2.1 Global Orally Disintegrating Tablet Excipient Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Orally Disintegrating Tablet Excipient Sales by Application (2021-2032)
  8. 5.2.3 Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2021-2032)
  9. 5.3 Global Orally Disintegrating Tablet Excipient Revenue by Application
  10. 5.3.1 Global Orally Disintegrating Tablet Excipient Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Orally Disintegrating Tablet Excipient Revenue by Application (2021-2032)
  12. 5.3.3 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2021-2032)
6 Global Orally Disintegrating Tablet Excipient Sales by Region
  1. 6.1 Global Orally Disintegrating Tablet Excipient Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Orally Disintegrating Tablet Excipient Sales by Region (2021-2032)
  3. 6.2.1 Global Orally Disintegrating Tablet Excipient Sales by Region (2021-2026)
  4. 6.2.2 Global Orally Disintegrating Tablet Excipient Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Orally Disintegrating Tablet Excipient Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Orally Disintegrating Tablet Excipient Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Orally Disintegrating Tablet Excipient Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Orally Disintegrating Tablet Excipient Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Orally Disintegrating Tablet Excipient Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Orally Disintegrating Tablet Excipient Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Orally Disintegrating Tablet Excipient Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Orally Disintegrating Tablet Excipient Revenue by Region
  1. 7.1 Global Orally Disintegrating Tablet Excipient Revenue by Region
  2. 7.1.1 Global Orally Disintegrating Tablet Excipient Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Orally Disintegrating Tablet Excipient Revenue by Region (2021-2026)
  4. 7.1.3 Global Orally Disintegrating Tablet Excipient Revenue by Region (2027-2032)
  5. 7.1.4 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Orally Disintegrating Tablet Excipient Revenue (2021-2032)
  8. 7.2.2 North America Orally Disintegrating Tablet Excipient Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Orally Disintegrating Tablet Excipient Revenue (2021-2032)
  11. 7.3.2 Europe Orally Disintegrating Tablet Excipient Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Orally Disintegrating Tablet Excipient Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Orally Disintegrating Tablet Excipient Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Orally Disintegrating Tablet Excipient Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Orally Disintegrating Tablet Excipient Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 BASF
  2. 8.1.1 BASF Company Information
  3. 8.1.2 BASF Business Overview
  4. 8.1.3 BASF Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BASF Orally Disintegrating Tablet Excipient Product Portfolio
  6. 8.1.5 BASF Recent Developments
  7. 8.2 JRS Pharma
  8. 8.2.1 JRS Pharma Company Information
  9. 8.2.2 JRS Pharma Business Overview
  10. 8.2.3 JRS Pharma Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 JRS Pharma Orally Disintegrating Tablet Excipient Product Portfolio
  12. 8.2.5 JRS Pharma Recent Developments
  13. 8.3 Roquette
  14. 8.3.1 Roquette Company Information
  15. 8.3.2 Roquette Business Overview
  16. 8.3.3 Roquette Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Roquette Orally Disintegrating Tablet Excipient Product Portfolio
  18. 8.3.5 Roquette Recent Developments
  19. 8.4 ABF Ingredients
  20. 8.4.1 ABF Ingredients Company Information
  21. 8.4.2 ABF Ingredients Business Overview
  22. 8.4.3 ABF Ingredients Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 ABF Ingredients Orally Disintegrating Tablet Excipient Product Portfolio
  24. 8.4.5 ABF Ingredients Recent Developments
  25. 8.5 DFE Pharma
  26. 8.5.1 DFE Pharma Company Information
  27. 8.5.2 DFE Pharma Business Overview
  28. 8.5.3 DFE Pharma Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 DFE Pharma Orally Disintegrating Tablet Excipient Product Portfolio
  30. 8.5.5 DFE Pharma Recent Developments
  31. 8.6 Evonik
  32. 8.6.1 Evonik Company Information
  33. 8.6.2 Evonik Business Overview
  34. 8.6.3 Evonik Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Evonik Orally Disintegrating Tablet Excipient Product Portfolio
  36. 8.6.5 Evonik Recent Developments
  37. 8.7 Merck KGaA
  38. 8.7.1 Merck KGaA Company Information
  39. 8.7.2 Merck KGaA Business Overview
  40. 8.7.3 Merck KGaA Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Merck KGaA Orally Disintegrating Tablet Excipient Product Portfolio
  42. 8.7.5 Merck KGaA Recent Developments
  43. 8.8 Ashland
  44. 8.8.1 Ashland Company Information
  45. 8.8.2 Ashland Business Overview
  46. 8.8.3 Ashland Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Ashland Orally Disintegrating Tablet Excipient Product Portfolio
  48. 8.8.5 Ashland Recent Developments
  49. 8.9 Meggle Pharma
  50. 8.9.1 Meggle Pharma Company Information
  51. 8.9.2 Meggle Pharma Business Overview
  52. 8.9.3 Meggle Pharma Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Meggle Pharma Orally Disintegrating Tablet Excipient Product Portfolio
  54. 8.9.5 Meggle Pharma Recent Developments
  55. 8.10 Shin-Etsu
  56. 8.10.1 Shin-Etsu Company Information
  57. 8.10.2 Shin-Etsu Business Overview
  58. 8.10.3 Shin-Etsu Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Shin-Etsu Orally Disintegrating Tablet Excipient Product Portfolio
  60. 8.10.5 Shin-Etsu Recent Developments
  61. 8.11 Fuji Chemical Industries
  62. 8.11.1 Fuji Chemical Industries Company Information
  63. 8.11.2 Fuji Chemical Industries Business Overview
  64. 8.11.3 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product Portfolio
  66. 8.11.5 Fuji Chemical Industries Recent Developments
  67. 8.12 McePharma (Vivesa holding)
  68. 8.12.1 McePharma (Vivesa holding) Company Information
  69. 8.12.2 McePharma (Vivesa holding) Business Overview
  70. 8.12.3 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product Portfolio
  72. 8.12.5 McePharma (Vivesa holding) Recent Developments
  73. 8.13 Cargill Incorporated
  74. 8.13.1 Cargill Incorporated Company Information
  75. 8.13.2 Cargill Incorporated Business Overview
  76. 8.13.3 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Cargill Incorporated Orally Disintegrating Tablet Excipient Product Portfolio
  78. 8.13.5 Cargill Incorporated Recent Developments
  79. 8.14 Daicel Corporation
  80. 8.14.1 Daicel Corporation Company Information
  81. 8.14.2 Daicel Corporation Business Overview
  82. 8.14.3 Daicel Corporation Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Daicel Corporation Orally Disintegrating Tablet Excipient Product Portfolio
  84. 8.14.5 Daicel Corporation Recent Developments
  85. 8.15 Anhui Sunhere Pharmaceutical
  86. 8.15.1 Anhui Sunhere Pharmaceutical Company Information
  87. 8.15.2 Anhui Sunhere Pharmaceutical Business Overview
  88. 8.15.3 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product Portfolio
  90. 8.15.5 Anhui Sunhere Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Orally Disintegrating Tablet Excipient Value Chain Analysis
  2. 9.1.1 Orally Disintegrating Tablet Excipient Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Orally Disintegrating Tablet Excipient Production Mode & Process
  6. 9.2 Orally Disintegrating Tablet Excipient Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Orally Disintegrating Tablet Excipient Distributors
  9. 9.2.3 Orally Disintegrating Tablet Excipient Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst